sarkosyl has been researched along with Disease Models, Animal in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyagi, A; Freyman, Y; Gentleman, SM; Halliday, GM; Kazmi, SA; Middleton, LT; Mordes, DA; Oehler, A; Olson, SH; Patel, S; Prusiner, SB; Woerman, AL | 1 |
| Finsen, B; Larsen, MR; Metaxas, A; Thygesen, C | 1 |
| Andoh, T; Inami, Y; Kuraishi, Y; Sasaki, A | 1 |
| Ando, K; Authelet, M; Brion, JP; Dedecker, R; Duyckaerts, C; Frédérick, C; Heraud, C; Kabova, A; Leroy, K; Potier, MC; Stygelbout, V; Suain, V; Yilmaz, Z | 1 |
| Chu, J; Craige, CP; Lauretti, E; Praticò, D | 1 |
| Bohrmann, B; Collin, L; Göpfert, U; Grüninger, F; Oroszlan-Szovik, K; Ozmen, L | 1 |
| Baine, AT; Delenclos, M; DeTure, M; Dickson, DW; Jones, DR; McLean, PJ; Murray, ME | 1 |
| Li, L; Park, KW | 1 |
| Delerue, F; Gladbach, A; Götz, J; Ittner, LM; Ke, YD | 1 |
| Iqbal, K; Korenova, M; Kovacech, B; Novak, M; Zilka, N | 1 |
| Allen, B; Atzori, C; Craxton, M; Crowther, RA; Emson, PC; Ghetti, B; Goedert, M; Holzer, M; Ingram, E; Jakes, R; Migheli, A; Smith, MJ; Spillantini, MG; Takao, M; Virdee, K; Yoshida, H | 1 |
| DeTure, M; Dickson, DW; Hutton, M; Lewis, J; McGowan, E; Sahara, N; Yen, SH | 1 |
| Dickson, D; Hutton, M; Ishizawa, T; Lewis, J; McGowan, E; Sahara, N; Vega, IE; Yen, SH | 1 |
| Biernat, J; Bujard, H; Drexler, D; Eckermann, K; Khlistunova, I; Mandelkow, E; Mandelkow, EM; Mocanu, MM; Nissen, A; Petrova, O; Rune, G; Schönig, K; Zhou, L | 1 |
14 other study(ies) available for sarkosyl and Disease Models, Animal
| Article | Year |
|---|---|
MSA prions exhibit remarkable stability and resistance to inactivation.
Topics: alpha-Synuclein; Animals; Biological Transport; Brain; Detergents; Disease Models, Animal; Fixatives; Formaldehyde; HEK293 Cells; Humans; Mice, Transgenic; Multiple System Atrophy; Muscle, Skeletal; Mutation; Prions; Protein Aggregates; Protein Stability; Sarcosine; Stainless Steel | 2018 |
Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Disease Models, Animal; Gene Ontology; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondrial Diseases; Mutation; Neuroglia; Neurons; Presenilin-1; Proteome; Sarcosine | 2018 |
Surfactant-induced chronic pruritus: Role of L-histidine decarboxylase expression and histamine production in epidermis.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Enzyme Induction; Epidermis; Histamine; Histamine H1 Antagonists; Histidine Decarboxylase; Male; Mast Cells; Mice, Inbred ICR; Narcotic Antagonists; Protein Processing, Post-Translational; Pruritus; Sarcosine; Signal Transduction; Sodium Dodecyl Sulfate; Surface-Active Agents; Time Factors; Up-Regulation | 2014 |
Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
Topics: Aged, 80 and over; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Female; Humans; Mice; Mice, Transgenic; Neurofibrillary Tangles; Neurons; Pilot Projects; Sarcosine; tau Proteins; Vaccination | 2014 |
Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzamides; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; Humans; Imatinib Mesylate; Mice; Mice, Transgenic; Mutation; Neuroblastoma; Peptide Fragments; Phosphorylation; Piperazines; Plaque, Amyloid; Presenilin-1; Proteins; Pyrimidines; Sarcosine; Statistics, Nonparametric; tau Proteins | 2014 |
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antibodies; Antibodies, Monoclonal; Blotting, Western; CA1 Region, Hippocampal; Disease Models, Animal; Disease Progression; Fluorescent Antibody Technique; Humans; Image Processing, Computer-Assisted; Lysosomes; Membrane Microdomains; Mice; Mice, Transgenic; Phosphorylation; Sarcosine; tau Proteins | 2014 |
Transmission of Soluble and Insoluble α-Synuclein to Mice.
Topics: Adaptation, Ocular; Age Factors; Aged; alpha-Synuclein; Animals; Brain; Calcium-Binding Proteins; Detergents; Disease Models, Animal; Exploratory Behavior; Female; Glial Fibrillary Acidic Protein; Humans; Lewy Body Disease; Male; Maze Learning; Mice; Mice, Transgenic; Microfilament Proteins; Microscopy, Electron; Muscle Strength; Platelet-Derived Growth Factor; Sarcosine | 2015 |
Cytoplasmic expression of mouse prion protein causes severe toxicity in Caenorhabditis elegans.
Topics: Animals; Animals, Genetically Modified; Caenorhabditis elegans; Cell Movement; Cytoplasm; Detergents; Disease Models, Animal; Endopeptidase K; Mice; Muscle Cells; Mutation; Prion Diseases; Prion Proteins; Prions; Protein Folding; Sarcosine; Solubility | 2008 |
Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Blood Glucose; Comorbidity; Diabetes Mellitus, Experimental; Disease Models, Animal; Formates; Humans; Mice; Mice, Transgenic; Mutation; Phosphorylation; Sarcosine; tau Proteins; Time Factors | 2009 |
CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.
Topics: Animals; Brain; Detergents; Disease Models, Animal; Disease Progression; Humans; Longitudinal Studies; Phosphorylation; Rats; Rats, Transgenic; Sarcosine; Severity of Illness Index; tau Proteins; Tauopathies | 2010 |
Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.
Topics: Amino Acid Substitution; Animals; Apoptosis; Benzothiazoles; Brain; Brain Chemistry; Cell Count; Disease Models, Animal; Homozygote; Humans; Immunohistochemistry; Mice; Mice, Transgenic; Motor Neurons; Neurodegenerative Diseases; Paraparesis; Phenotype; Phosphorylation; Sarcosine; Solubility; Spinal Cord; tau Proteins; Thiazoles | 2002 |
Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility.
Topics: Age Factors; Amino Acid Substitution; Animals; Binding Sites; Brain; Brain Chemistry; Detergents; Disease Models, Animal; Disease Progression; Electrophoresis, Polyacrylamide Gel; Female; Humans; Macromolecular Substances; Male; Mice; Mice, Transgenic; Mutation; Phosphorylation; Sarcosine; Sex Factors; Solubility; tau Proteins; Tauopathies | 2002 |
Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
Topics: Age Factors; Alzheimer Disease; Animals; Antibodies; Antibody Specificity; Blotting, Western; Brain; Cross Reactions; Disease Models, Animal; Female; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Precipitin Tests; Sarcosine; Solubility; Spinal Cord; tau Proteins; Tauopathies | 2004 |
The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
Topics: Age Factors; Animals; Cell Death; Detergents; Disease Models, Animal; Gene Expression; Humans; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Mutation; Neurofibrillary Tangles; Neurons; Phosphorylation; Protein Structure, Tertiary; Sarcosine; Silver Staining; Synapses; tau Proteins; Tauopathies | 2008 |